You are here:

Archived: Esomeprazole (Nexium®)

Advice

Following a full submission

Esomeprazole (Nexium®) is not recommended for use within NHS Scotland for the prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory (NSAID) therapy in patients at risk.

When compared to placebo, esomeprazole reduces the rate of gastro-duodenal ulcers associated with NSAID therapy in at-risk patients. There are no comparisons of esomeprazole with other proton pump inhibitors for this indication. The economic case has not been demonstrated.

Drug Details

Drug Name: Esomeprazole (Nexium®)
SMC Drug ID: 257/06
Manufacturer: AstraZeneca UK Ltd
Indication: Prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory (NSAID) therapy
BNF Category:
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 12 June 2006

Current Advice

Full submission 12 June 2006

Back